← SynDRA
ABBV-744
SynDRA canonical compound SYN0039603 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | BRD2 |
|---|
| Mechanism of action | bromodomain inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BET bromodomain inhibitor
- BRD4 INHIBITOR
- BRD3 INHIBITOR
- BRD2 INHIBITOR
Cross-references
Synonyms
- ABBV744
- ABBV 744
- OEDSFMUSNZDJFD-UHFFFAOYSA-N
- N-ethyl-4-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide
- SCHEMBL19463409
- EX-A2713
- ACN-054460
- HY-112090
- CS-0043318
- 9MX546E2SF
- RefChem:927147
- DTXCID301507226
- UNII-9MX546E2SF
- US10633379, Example 82
- HWV
- orb1302642
- ABBV-744?
- C28H30FN3O4
- GTPL10730
- BDBM439497
- BDBM439547
- GLXC-21221
- US10633379, Example 35
- EBC-43021
- NSC812415
- s8723
- AKOS037515627
- NSC-812415
- NCGC00651745-01
- AC-36257
- BA166477
- BS-16488
- DA-50082
- PD133034
- T4697
- C74031
- Z3325129513
Look up ABBV-744 in the interactive SynDRA portal →